Bayer CropScience Ltd

Bayer CropScience Ltd has experienced a notable shift in its technical momentum, with key indicators signalling a bearish trend across multiple timeframes. Despite a recent upgrade in its Mojo Grade from Sell to Hold, the stock’s price action and technical parameters suggest caution for investors amid persistent downward pressure and mixed momentum signals.

A sharp decline in the last two sessions has dragged Bayer CropScience Ltd to a fresh 52-week low of Rs 3864.95 on 09 Jun 2026, marking a significant 29.5% drop from its 52-week high of Rs 5487.90. This downturn comes amid broader market weakness, but the stock's underperformance notably exceeds that of the Sensex, which itself is nearing a 52-week low.

Bayer CropScience Ltd, a key player in the Pesticides & Agrochemicals sector, has seen its investment rating upgraded from Sell to Hold as of 7 September 2026. This change reflects a nuanced improvement across technical indicators, valuation metrics, financial trends, and overall quality assessments, signalling a cautious but more optimistic outlook for investors amid mixed long-term performance.

Bayer CropScience Ltd, a small-cap player in the Pesticides & Agrochemicals sector, has witnessed a nuanced shift in its technical momentum, reflecting a complex interplay of bearish and bullish signals across multiple timeframes. Despite a marginal day change of 0.03%, the stock’s technical indicators reveal a transition from a bearish to a mildly bearish trend, prompting a reassessment of its near-term outlook.

Bayer CropScience Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 10 August 2026. However, the analysis and financial metrics presented here reflect the stock's current position as of 02 September 2026, providing investors with the latest insights into the company’s performance and outlook.

For the third consecutive session, Bayer CropScience Ltd has seen its share price decline, culminating in a fresh 52-week low of Rs 4,012.6 on 31 Aug 2026. This marks a significant 26.9% drop from its 52-week high of Rs 5,487.9, underscoring persistent downward pressure despite some positive financial indicators.

A 25.7% decline from its 52-week high of Rs 5,576.45 has dragged Bayer CropScience Ltd to a fresh 52-week low of Rs 4,028.9 on 25 Aug 2026, marking a continuation of its underwhelming performance amid broader market weakness.

Bayer CropScience Ltd is rated Sell by MarketsMOJO, with this rating last updated on 10 August 2026. While the rating change occurred on that date, the analysis and financial metrics discussed here reflect the stock's current position as of 22 August 2026, providing investors with the latest insights into the company's performance and outlook.

Bayer CropScience Ltd, a key player in the Pesticides & Agrochemicals sector, has seen its investment rating downgraded from Hold to Sell as of 10 August 2026. This shift reflects deteriorating technical indicators, expensive valuation metrics, and subdued financial trends despite some operational strengths. The company’s current Mojo Score stands at 44.0, with a Mojo Grade of Sell, signalling caution for investors amid ongoing market challenges.

Bayer CropScience Ltd has experienced a notable shift in its technical momentum, with key indicators signalling a bearish trend across multiple timeframes. Despite a recent upgrade in its Mojo Grade from Sell to Hold, the stock’s price action and technical parameters suggest caution for investors amid persistent downward pressures.

Bayer CropScience Ltd, a small-cap player in the Pesticides & Agrochemicals sector, has seen its investment rating upgraded from Sell to Hold as of 3 August 2026. This change reflects a nuanced improvement across technical indicators, financial trends, valuation metrics, and quality assessments, signalling a cautious but positive outlook for investors amid challenging market conditions.

Bayer CropScience Ltd has experienced a notable shift in its technical momentum, moving from a bearish stance to a mildly bearish outlook, reflecting a complex interplay of technical indicators. Despite a modest day gain of 1.58%, the stock’s mixed signals across MACD, RSI, moving averages, and other momentum indicators suggest cautious optimism amid ongoing volatility in the pesticides and agrochemicals sector.

Bayer CropScience Ltd, a key player in the Pesticides & Agrochemicals sector, has seen its investment rating downgraded from Hold to Sell as of 27 Jul 2026. This shift reflects a combination of deteriorating technical indicators, expensive valuation metrics, subdued financial trends, and overall quality assessments, signalling caution for investors despite some positive quarterly financial results.

Bayer CropScience Ltd has experienced a notable shift in its technical momentum, with key indicators signalling a bearish trend despite a recent upgrade in its Mojo Grade from Sell to Hold. The stock’s price momentum and technical parameters reveal a complex picture for investors navigating the pesticides and agrochemicals sector amid broader market pressures.

Bayer CropScience Ltd has seen its investment rating upgraded from Sell to Hold, reflecting a nuanced improvement across technical indicators, valuation metrics, financial trends, and overall quality. This shift comes amid a backdrop of mixed long-term returns but encouraging recent financial performance and a stabilising technical outlook.

Bayer CropScience Ltd has exhibited a notable shift in its technical momentum, moving from a bearish stance to a mildly bearish outlook, reflecting a complex interplay of technical indicators. Despite a 2.18% gain on 22 Jul 2026, the stock’s broader trend remains cautious, with mixed signals from MACD, RSI, moving averages, and volume-based indicators suggesting a nuanced market sentiment for this small-cap player in the pesticides and agrochemicals sector.